2016

June 09, 2016
BTG Joins Global Liver Institute Partnership Network to Transform Care for Liver Cancer Patients

London, UK, 09 June 2016 BTG, a global leader in interventional oncology, announced today that it has joined the Global Liver Institute’s Partnership Network as a founding member. The Global...

June 02, 2016
BTG to Initiate Multi-Centre TARGET Study Evaluating Dosimetry for 90Y Radioembolisation Therapy in Patients With Hepatocellular Carcinoma

02 June 2016 BTG plc (LSE: BTG), a global specialist healthcare company, today announced plans to initiate the TheraSphere® Advanced Dosimetry Retrospective Global Study Evaluation in...

May 26, 2016
New study highlights potential cost savings using Y90 glass microspheres in hcc

WASHINGTON D.C, 26 May 2016 New study highlights potential cost savings when using yttrium-90 glass microspheres for treatment of hepatocellular carcinoma TARE (transarterial radio-embolization)...

May 17, 2016
BTG plc: Final Results 2016

London, UK, 17 May 2016 BTG plc (LSE: BTG), the specialist healthcare company, today announces its final results for the year ended 31 March 2016. Click here to download the results release PDF

May 06, 2016
BTG plc acquires Galil Medical, a leader in cryoablation

London, UK, 06 May 2016 Builds on BTG’s leadership in Interventional Oncology, expanding franchise into attractive and complementary ablation market Galil Medical is a leader in cryoablation of...

Show 5102550100 per page
Top